Diagnostic Approach for Suspected Pulmonary Embolism
Begin with validated clinical prediction rules (Wells score or revised Geneva score) to stratify pretest probability, then proceed with D-dimer testing (using age-adjusted thresholds for patients >50 years) for low/intermediate probability patients, or proceed directly to CT pulmonary angiography for high probability patients. 1
Risk Stratification Using Clinical Prediction Rules
All patients with suspected PE must be stratified using validated clinical decision tools before ordering any tests. 1, 2
- Wells Score assigns points for: clinical signs of DVT (3 points), PE as likely diagnosis as or more likely than alternative (3 points), heart rate >100 (1.5 points), immobilization/surgery in past 4 weeks (1.5 points), previous PE/DVT (1.5 points), hemoptysis (1 point), and malignancy (1 point) 3
- Low probability: Wells score ≤4 or simplified Geneva score 0-1 (PE prevalence ~3-13%) 2, 3
- Intermediate probability: Wells score 2-6 or simplified Geneva score 2-4 (PE prevalence ~16-26%) 2
- High probability: Wells score >6 or simplified Geneva score ≥5 (PE prevalence ~36-50%) 2, 3
Diagnostic Algorithm by Risk Category
Low Pretest Probability Patients
Apply the Pulmonary Embolism Rule-Out Criteria (PERC) before ordering any laboratory tests. 1, 4
- PERC criteria (all 8 must be met): age <50 years, heart rate <100 bpm, oxygen saturation ≥95% on room air, no unilateral leg swelling, no hemoptysis, no recent trauma/surgery within 4 weeks, no prior VTE history, and no hormone use 2, 4
- If all 8 PERC criteria are met: PE is ruled out, no further testing needed 1, 2
- If any PERC criterion is not met: Proceed to high-sensitivity D-dimer testing 1, 2
Critical pitfall: PERC should only be applied to patients already determined to have low pretest probability—never use it as a general screening tool 2
Intermediate Pretest Probability Patients
Proceed directly to high-sensitivity D-dimer testing without applying PERC. 1, 2
High Pretest Probability Patients
Proceed directly to CT pulmonary angiography (CTPA) without D-dimer testing. 1, 2, 3
- A negative D-dimer cannot safely exclude PE when pretest probability is high 2, 3
- Ordering D-dimer in high probability patients wastes time and resources 2
D-Dimer Testing and Interpretation
Use only high-sensitivity D-dimer assays (ELISA or turbidimetric methods) with sensitivity ≥95%. 2
Age-Adjusted D-Dimer Thresholds
For patients >50 years old, use age-adjusted D-dimer cutoff (age × 10 ng/mL) instead of the standard 500 ng/mL threshold. 1, 2
- Patients ≤50 years: Use standard cutoff <500 ng/mL 2, 3
- Patients >50 years: Use age-adjusted cutoff (age × 10 ng/mL) 1, 2
- Age-adjusted thresholds maintain sensitivity >97% while significantly improving specificity, which drops to only 10% in patients >80 years using standard cutoffs 2
- This approach increases the proportion of older patients in whom PE can be excluded from 6.4% to 30% without additional false-negative findings 2
D-Dimer Results
- If D-dimer is below the appropriate threshold: PE is ruled out, no imaging needed (negative predictive value 99.5%) 2, 4, 3
- If D-dimer is elevated: Proceed immediately to CTPA 2, 3
Critical pitfall: Never use positive D-dimer alone to diagnose PE—confirmation with imaging is mandatory 3
Imaging Studies
CT Pulmonary Angiography (CTPA)
CTPA is the imaging test of first choice with sensitivity 83% and specificity 96%. 3, 5, 6
- Indications for CTPA: High pretest probability patients (without D-dimer) or low/intermediate probability patients with elevated D-dimer 1, 3
- Positive CTPA: Segmental or more proximal filling defect confirms PE diagnosis without further testing 3
- Negative CTPA: In low/intermediate probability patients, effectively rules out PE without additional testing 3, 5
- Negative CTPA in high probability patients: Consider additional testing such as compression ultrasonography of lower extremities 3
Ventilation-Perfusion (V/Q) Scanning
Reserve V/Q scanning for patients with contraindications to CTPA (renal insufficiency, contrast allergy) or when CTPA is unavailable. 1, 3
- V/Q SPECT has the lowest rate of non-diagnostic results and lower radiation exposure than CTPA 3
- Normal perfusion scan rules out PE without further testing 3
Compression Ultrasonography
Consider compression ultrasonography in patients with clinical signs of DVT or as an adjunct in high probability patients with negative CTPA. 1, 4, 3
- Finding proximal DVT is sufficient to warrant anticoagulation without further PE imaging 3
- Color Doppler imaging is the investigation of choice for suspected lower limb DVT 1
Special Populations
Hemodynamically Unstable Patients
Perform immediate bedside transthoracic echocardiography to assess for right ventricular dysfunction. 3
- Echocardiographic findings of RV dysfunction, RV dilatation, pulmonary artery enlargement, and tricuspid regurgitation can justify emergency reperfusion therapy without further testing 1, 3
- If patient can be stabilized, proceed directly to CTPA without D-dimer testing 3
Hospitalized Patients
D-dimer specificity is lower in inpatients due to comorbidities, but testing remains appropriate as sensitivity stays high. 2
- Consider proceeding more directly to imaging rather than relying heavily on D-dimer in hospitalized patients 3
- A normal D-dimer with appropriate pretest stratification still prevents unnecessary imaging 2
Pregnant Patients
Consider lower-extremity venous ultrasonography before CT to reduce radiation exposure, especially in first trimester. 2
- Refer to pregnancy-specific PE diagnostic algorithms as standard D-dimer thresholds and radiation considerations differ 3
Common Pitfalls to Avoid
- Never apply PERC to patients >50 years old, as age <50 is a required criterion 2
- Never use standard 500 ng/mL D-dimer cutoff in patients >50 years, as this leads to unnecessary imaging due to poor specificity 2
- Never order D-dimer in high pretest probability patients—proceed directly to imaging 2, 3
- Never skip pretest probability assessment, as D-dimer and imaging interpretation depend critically on it 3
- Never use point-of-care D-dimer assays when laboratory-based tests are available, as they have lower sensitivity (88% vs. 95%) 2